Table 2 Cox regression models on outcome by CD15⁺, MPO⁺, CD15⁺/MPO⁺ immune cells, or CD15⁺ tumor cells (CD15⁺ TC) in primary breast tumors.

Primary tumor

CD15⁺ few cells

CD15⁺ many cells

MPO⁺ few cells

MPO⁺ many cells

CD15⁺MPO⁺ few cells

CD15⁺MPO⁺ many cells

CD15⁺ TC – few cells

CD15⁺ TC – many cells

1.04 (0.67–1.63)

0.67 (0.33–1.36)

1.26 (0.83–1.90)

2.52 (1.33–4.78)

1.20 (0.81–1.77)

3.77 (1.65–8.60)

0.72 (0.31–1.68)

0.93 (0.51–1.70)

0.85

0.27

0.27

0.004

0.37

0.002

0.45

0.80

0.88 (0.51–1.55)

0.58 (0.22–1.50)

0.71 (0.39–1.3)

1.65 (0.74–3.69)

0.94 (0.55–1.60)

3.04 (1.13–8.19)

0.92 (0.34–2.52)

0.56 (0.26–1.21)

0.67

0.26

0.27

0.22

0.81

0.028

0.87

0.14

1.28 (0.81-2.00)

0.87 (0.43–1.76)

1.17 (0.76–1.79)

2.35 (1.23–4.49)

0.96 (0.64–1.45)

4.12 (1.78–9.57)

0.99 (0.43–2.28)

0.49 (0.24–1.02)

0.288

0.694

0.480

0.010

0.856

< 0.001

0.989

0.057

1.15 (0.66-2.00)

0.72 (0.26–1.98)

0.64 (0.36–1.14)

1.33 (0.61–2.88)

0.75 (0.43–1.31)

2.04 (0.75–5.54)

1.00 (0.36–2.85)

0.30 (0.12–0.74)

0.61

0.53

0.13

0.48

0.31

0.16

0.99

0.009